MSC has announced its restart plans for cruising from U.S. ports beginning this August. The announcement follows CDC approval of the Company’s Phase 2A Port Agreements for PortMiami and Port Canaveral as well as the provisional approval of its request to conduct a simulation cruise, to be held on MSC Meraviglia on from PortMiami on 17 July 2021.
MSC Meraviglia will kick off MSC Cruises’ restart starting 2 August 2021, with 3- and 4-night cruises from Miami to The Bahamas and featuring MSC Cruises’ exclusive new private island destination, Ocean Cay MSC Marine Reserve.
Then, starting 18 September 2021, MSC Meraviglia will add 7-night cruises from Miami to The Bahamas and Caribbean, including Ocean Cay MSC Marine Reserve.
MSC Divina will resume cruising from Orlando (Port Canaveral) on 16 September 2021, offering 3-, 4- and 7-night cruise options from to The Bahamas and Caribbean, also including stops at Ocean Cay MSC Marine Reserve.
Commenting, Gianni Onorato, CEO of MSC Cruises, said: “With our vast experience cruising in Europe since August 2020 along with our industry-leading health and safety protocol, our U.S. guests can book with confidence knowing we are well prepared for a successful restart in that market.”
“To ensure the safest experience for our guests, we previously announced a fleet-wide vaccination program for all crew, and we expect that the majority of our guests booking a cruise this summer will plan to be vaccinated prior to sail. The rapid distribution of vaccines in the U.S. has been a positive step toward helping vacationers get back to traveling, and we encourage our guests to take advantage of this added layer of protection when resuming travel this summer.”
MSC Cruises will reveal additional itinerary details for cruises on board MSC Meraviglia and MSC Divina in the coming week, as well as health and safety measures and guidelines for guests. Cruises will welcome both vaccinated and non-vaccinated guests. Those who are not vaccinated or unable to verify vaccination will be subject to requirements such as additional testing, as well as restrictions, which will be announced at a later date.